Clinical significance of spread through air spaces according to EGFR mutation status in lung adenocarcinoma
Japanese Journal of Clinical Oncology · 13.11.2026 · 56 (11) · 1395-1403
DOI: 10.1093/jjco/hyag129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 18.08.2026. Verfasst von Asato Hashinokuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1347, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Mutation, Adenocarcinoma of Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objectives
Spread through air spaces (STAS) is a poor prognostic pathological feature recently included as a histological factor in the ninth edition of the TNM (tumor, node, and metastasis) classification. However, its clinical significance in lung adenocarcinoma with epidermal growth factor receptor (EGFR) gene mutations remains unclear. Here, we aimed to evaluate the clinical significance of STAS according to EGFR mutation status.
Methods
We retrospectively reviewed 347 patients with completely resected pathological stage 0–IIIB lung adenocarcinoma who were evaluated for both STAS and EGFR mutations between 2015 and 2022. We investigated the association between clinicopathological features and STAS and analyzed its prognostic relevance based on EGFR mutation status.
Results
STAS and EGFR mutations were present in 85 (24.5%) and 178 (51.3%) patients, respectively. In patients with EGFR-mutated lung adenocarcinoma, STAS was significantly more prevalent in those with exon 19 deletions than those with the L858R mutation (P = .012). STAS was significantly markedly associated with poorer recurrence-free and overall survival in patients both with (P < .001 and P < .001, respectively) and without (P = .003 and P = .023, respectively) EGFR mutations. Multivariable analysis revealed that STAS was an independent prognostic factor for recurrence-free and overall survival in patients with EGFR mutations (P < .001 and P = .020, respectively). However, STAS was not an independent predictor in patients without EGFR mutations.
Conclusions
STAS is a key pathological feature of lung adenocarcinoma and holds considerable clinical relevance, particularly in EGFR-mutated lung adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Oncology, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1347, Japan.
- Department of Pathology, NHO Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1347, Japan.
- Department of Biostatistics, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
ORCID-Profile: Asato Hashinokuchi, Naoki Haratake, Masafumi Yamaguchi
Zitieren
APA
Hashinokuchi, A., Kosai, K., Haratake, N., Fujishita, T., Shimamatsu, S., Kometani, T., Kawabata, T., Toyozawa, R., Taguchi, K., Shimokawa, M., & Yamaguchi, M. (2026). Clinical significance of spread through air spaces according to EGFR mutation status in lung adenocarcinoma. Japanese Journal of Clinical Oncology, 56(11), 1395-1403. https://doi.org/10.1093/jjco/hyag129
Vancouver
Hashinokuchi A, Kosai K, Haratake N, Fujishita T, Shimamatsu S, Kometani T, et al. Clinical significance of spread through air spaces according to EGFR mutation status in lung adenocarcinoma. Japanese Journal of Clinical Oncology. 2026;56(11):1395-1403. doi:10.1093/jjco/hyag129
BibTeX
@article{Hashinokuchi2026,
author = {Hashinokuchi, Asato and Kosai, Keisuke and Haratake, Naoki and Fujishita, Takatoshi and Shimamatsu, Shinichiro and Kometani, Takuro and Kawabata, Toshiaki and Toyozawa, Ryo and Taguchi, Kenichi and Shimokawa, Mototsugu and Yamaguchi, Masafumi},
title = {Clinical significance of spread through air spaces according to EGFR mutation status in lung adenocarcinoma},
journal = {Japanese Journal of Clinical Oncology},
year = {2026},
volume = {56},
number = {11},
pages = {1395--1403},
doi = {10.1093/jjco/hyag129}
}
EUVIMED